A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters New trial data suggests Novo Nordisk‘s weight loss drug Wegovy edges out rival treatments on heart condition risk reduction, in good news for the Danish pharma giant as it…
LONDON — Shares of Danish pharmaceutical giant Novo Nordisk were 3% higher in early deals Monday, after the company released trial data suggesting its blockbuster drug Wegovy outperforms major rivals in heart disease risk reduction. The study found continued users of semaglutide, a weight management drug branded as Wegovy, had up to a 57% greater reduction…
The Club’s 10 things to watch Wednesday, Aug. 20 — Today’s newsletter was written by Investing Club editor Kevin Stankiewicz. 1. Wall Street was set to open slightly lower today after the S & P 500 closed lower yesterday for the third session in a row. Investors were parsing the latest retail earnings this morning….
Check out the companies making headlines in premarket trading. Dayforce — The software stock surged more than 24% after people familiar with the matter told Bloomberg that Thoma Bravo is currently engaged in talks to acquire Dayforce and could do so in the coming weeks. Sunrun — Stock in the solar panel company gained 4%….
The Club’s 10 things to watch Monday, Aug. 18 — Today’s newsletter was written by Zev Fima, the Club’s portfolio analyst. 1. Stocks are poised to start the week a bit lower. Crypto is continuing to sell off, and the yield on the 10-year Treasury note is down slightly to 4.295%. Oil and gold slightly…
The stock market has been on a tear over the past month, as Wall Street mulled over quarterly earnings reports, President Donald Trump ‘s tariff moves, and the Federal Reserve’s next monetary policy decision. Since last month’s third annual meeting of the CNBC Investing Club, the S & P 500 and Nasdaq hit nine and…
My top 10 things to watch Monday, Aug. 4, 2025 1. Wall Street was bouncing back Monday morning after a tough week. Friday was crazy, with a terrible jobs report and President Donald Trump firing the BLS head, plus a Fed governor resigning. Trump is expected to announce replacements for each in the coming days….
Wall Street ended a busy week of earnings, economic data and policy decisions with a thud, as a weak jobs report renewed concerns about the health of the U.S. economy in the face of President Donald Trump’s ever-shifting tariff policy. In the week ahead, investors will look to the latest batch of earnings for additional…
CNBC’s Jim Cramer walked investors through another week of earnings season, honing in on reports from Palantir, Berkshire Hathaway, Disney and Eli Lilly. “We’re still in earnings Hades, but at least it’s getting a little cooler out there,” he said. “That’s right, we’ve now gotten over the hump of the big-time growth stocks, the hyperscalers,…
My top 10 things to watch Wednesday, July 30 1. Wall Street is on pace for a flat open ahead of a busy day for the market. Federal Reserve decision at 2 p.m. ET followed by Chair Jerome Powell’s press conference a half hour later. After the close, we hear from Club names Meta Platforms…